Fusafungine-containing medicines should be withdrawn, says European Medicines Agency - The Pharmaceutical Journal
Bioparox FUSAFUNGINUM Nasal Spray 50mg / 10ml LABORATORY SERVIER - Running Nose - Medicaments
Locabiotal - Hekimce
Fusafungine Art 31 - Annex I
Pharmaceutics | Free Full-Text | Dry Powder for Pulmonary Delivery: A Comprehensive Review
(PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study
Pharmacovigilance Risk Assessment Committee (PRAC)
PRAC recommends that fusafungine nose and mouth sprays are no longer marketed
Return Locabiosol/Bioparox/Locabiotal/Fusafungine BACK to the Market | Facebook
The Parenteral Society Web Page
Fusafungine - Wikipedia
How to obtain bioparox back for the patients? We are waiting for voices, ideas and directions of activities... - Return Locabiosol/Bioparox/Locabiotal/Fusafungine BACK to the Market | Facebook
Efficacy and Acceptability of Fusafungine*, a Local Treatment for Both Nose and Throat Infections, in Adult Patients with Upper
EMA Starts Safety Review of Fusafungine Nasal, Mouth Sprays
Laboratório recolhe medicamento contendo fusafungina - Portal CRM-PR
MR DIAGNOSTIC on Twitter: "Lékový ústav nedoporučuje používat sprej Bioparox: #bioparox #PRAC #fusafungin #SUKL #lek https://t.co/l9aP3OMnsP https://t.co/EBEdDNibTG" / Twitter
Fusafungine | C33H57N3O9 - PubChem
Locabiotal (discontinued in the UK - December 2005)
Fusafungine | S528581 | >98% (or refer to the COA) | smolecule
Return Locabiosol/Bioparox/Locabiotal/Fusafungine BACK to the Market | Facebook
PDF) Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact study
LOCABIOTAL ® - Foglietto Illustrativo
